SCHEMBL24083554

SCHEMBL24083554

C=C=Cc1c(C)c(CCC)c(C)n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20159870 0.66
SCHEMBL27719435 0.60 NOS2 (0.34)
SCHEMBL6476378 0.55 SMN1; SMN2 (0.37)
SCHEMBL19538924 0.55 GPR3 (0.56)
SCHEMBL16110137 0.54 CCR5 (0.41)
SCHEMBL2309435 0.53 KDM4E (0.38)
SCHEMBL12926006 0.53 KDM5A (0.34)
SCHEMBL16002393 0.53 KDM5A (0.32)
SCHEMBL12844283 0.52 SMN1; SMN2 (0.42)
SCHEMBL11647113 0.51 RAB9A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919474-A1 HBV INHIBITOR AND USE THEREOF Xi'An Xintong Pharmaceutical Research Co., Ltd. (CN) 2021-12-08 EP disclosed